Document Detail


Effects of oral administration of rotenone on gastrointestinal functions in mice.
MedLine Citation:
PMID:  23281940     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Background  The systemic rotenone model of Parkinson's disease (PD) accurately replicates many aspects of the pathology of human PD, especially neurodegeneration of the substantia nigra and lesions in the enteric nervous system (ENS). Nevertheless, the precise effects of oral rotenone on the ENS have not been addressed yet. This study was therefore designed to assess the effects of a chronic oral treatment by rotenone on enteric neurochemical phenotype, gastrointestinal (GI) motility, and intestinal epithelial barrier permeability. Methods  Male C57BL6N mice received once daily oral rotenone administration for 28 days. GI functions were analyzed 4 weeks after rotenone treatment. Gastrointestinal motility was assessed by measuring gastric emptying, total transit time, fecal pellet output, and bead latency. Intestinal barrier permeability was evaluated both in vivo and ex vivo. The number of enteric neurons and the enteric neurochemical phenotype were analyzed by immunohistochemistry. Tyrosine hydroxylase (TH) immunostaining of dopaminergic neurons of the substantia nigra was performed in a subset of animals. Key Results  Mice treated orally with rotenone had a decrease in fecal pellet output and in jejunal alpha-synuclein expression as compared with control animals. This was associated with a significant decrease in TH-immunoreactive neurons in the substantia nigra. No change in gastric emptying, total transit time, intestinal epithelial barrier permeability, and enteric neurochemical phenotype was observed. Conclusions & Inferences  Chronic oral treatment with rotenone only induced minor changes in the ENS and did not recapitulate the GI abnormalities seen in PD, while it replicates neurodegeneration of the substantia nigra.
Authors:
M Tasselli; T Chaumette; S Paillusson; Y Monnet; A Lafoux; C Huchet-Cadiou; P Aubert; S Hunot; P Derkinderen; M Neunlist
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-3
Journal Detail:
Title:  Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society     Volume:  -     ISSN:  1365-2982     ISO Abbreviation:  Neurogastroenterol. Motil.     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-3     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9432572     Medline TA:  Neurogastroenterol Motil     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2013 Blackwell Publishing Ltd.
Affiliation:
Inserm, U913, Nantes, France University Nantes, Nantes, France CHU Nantes, Institut des Maladies de l'Appareil Digestif, Nantes, France CNRS, UMR 7225, Experimental Therapeutics of Neurodegeneration, Paris, France UPMC Univ Paris 06, UMR_S975, Paris, France INSERM, UMR_S975, CRICM, Paris, France Inserm, U1087, CNRS U6291, Nantes, France Department of Neurology, CHU Nantes, Nantes, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Similarities in the neural signature for the processing of behaviorally categorized and uncategorize...
Next Document:  Personalized cloud-based bioinformatics services for research and education: use cases and the elast...